The path to the first cannabis prescription is long for many people. Not because the system intentionally makes it difficult – even though that’s how it can feel after years of struggling with health insurance companies, skeptical general practitioners, and confusing application forms. But rather because half-knowledge, misinformation, and outdated reports about the situation in Germany still cloud the picture.
📑 Inhaltsverzeichnis
- What the Medicinal Cannabis Act means for patients
- Cannabis on prescription: Medical prerequisites at a glance
- Finding the right doctor: General practitioner, specialist, or telemedicine?
- Health insurance application for cannabis on prescription: How to do it right
- Private prescription and self-payers: The quick alternative to health insurance application
- From prescription to dispensing: Cannabis at the pharmacy
- 💬 Fragen? Frag den Hanf-Buddy!
Since April 1, 2024, much has changed fundamentally. The Medicinal Cannabis Act (MedCanG) has removed cannabis from the Controlled Substances Act. Since then, doctors can prescribe it on a standard prescription form – something that previously was only possible through the bureaucratically cumbersome controlled substances prescription. This is no small matter. It is one of the most significant breakthroughs in the history of cannabis medicine in Germany – and it has noticeably simplified access to medicinal cannabis for hundreds of thousands of patients.
This article explains step by step what the path to a cannabis prescription actually looks like: which prerequisites you need to meet, which doctors you can approach, what you can expect from your health insurance – and what you can’t – and what alternatives are available to you if the conventional route doesn’t work.
What the Medicinal Cannabis Act means for patients
The MedCanG, which came into force on April 1, 2024, has reorganized the legal framework of cannabis supply in Germany. The decisive difference from the old rules lies not only in the prescription form, but in the fundamental treatment of medicinal cannabis as a regular pharmaceutical product.
Previously, cannabis for medical purposes was classified as a controlled substance and had to be prescribed on a special controlled substances prescription, which involved increased documentation efforts for pharmacies and doctors. Many doctors shied away from prescribing it simply because of this additional bureaucratic burden. With the MedCanG, that’s a thing of the past. Medicinal cannabis is now handled like any other medication – with standard prescription forms and the same pharmacy processes as conventional pain relievers or antidepressants.
However, this doesn’t mean that anyone can simply walk into a waiting room and leave with a prescription. The medical requirements still exist. Cannabis remains a pharmaceutical that must be based on a sound medical decision – and that’s the right way to do it. But if you have a legitimate medical condition and meet the prerequisites, you have significantly better chances today than you did just a few years ago. The balance sheet of legalization is clearly positive on this point: the simplified access has worked, even if critics see a need for further reforms.
Another important point: The MedCanG eliminates the previous restriction to certain conditions explicitly listed in the law. The prescribing decision rests entirely with the doctor. This gives doctors more discretion – and patients more options to present their individual situation in an open conversation.
Cannabis on prescription: Medical prerequisites at a glance
The central question is: When is cannabis on prescription a realistic option for you? The answer is more nuanced than a simple yes or no.
Doctors may prescribe cannabis when a serious illness is present and either no other treatment options are effective anymore or the side effects of previous treatment are no longer tolerable. It’s about patients for whom conventional medicine has reached its limits – not about people who are simply curious or view cannabis as a lifestyle product.
In practice, medicinal cannabis is used primarily for chronic pain, spastic disorders such as multiple sclerosis, nausea and vomiting in the context of chemotherapy, and certain psychiatric disorders such as PTSD and treatment-resistant depression. The fact that the effectiveness of cannabis against chronic pain is now well-established scientifically has increased pressure on health insurers and doctors to take this approach seriously. Other diagnoses relevant in clinical practice include fibromyalgia, rheumatic diseases, ADHD, severe sleep disorders, and certain neurological conditions.
What’s crucial is that you bring a documented medical history. A doctor seeing you for the first time today will in most cases not prescribe cannabis without knowing which therapies you have already tried without sufficient success. Test results, medical letters, discharge reports, and a complete medication history are not just bureaucratic formalities – they are the foundation on which the medical decision is made. If you don’t have these documents ready, you should first ask your treating doctor or clinic and gather all relevant documents from the past two years.
What many don’t know: Even patients who have exhausted all treatment options and all other possibilities seem exhausted have special chances. For them in particular, cannabis can be a last hope. Our article Exhausted all options – and then? How hemp gives patients new hope describes this path in detail.
Finding the right doctor: General practitioner, specialist, or telemedicine?
The first practical hurdle is finding a doctor who prescribes cannabis – and this is still not trivial, even though the situation has noticeably improved since 2024.
In principle, any licensed physician may prescribe medicinal cannabis. The only exceptions are dentists and veterinarians. This includes general practitioners, internists, neurologists, pain therapists, and psychiatrists. However, practice shows a mixed picture: many general practitioners are still uncertain about the subject or fundamentally reject it. This is not due to bad intentions, but often to a lack of continuing education and uncertainty about dosing and strain selection.
Specialists in pain medicine and neurology are more open-minded by experience – especially since chronic pain and neurological diseases are the most common indications for medicinal cannabis. A conversation with your existing specialist is therefore always the first recommended step before exploring new avenues. Those who have difficulty finding a cooperative doctor often find recommendations from their region on patient portals and in cannabis communities.
The rise of telemedicine has fundamentally democratized this process. Platforms enable patients to speak with licensed doctors via video consultation without having to visit a practice in person. For people in rural areas, for chronically ill people who have difficulty leaving the house, or for all those who cannot find a specialized doctor nearby, this is a real game-changer. Costs vary considerably depending on the provider: initial consultations range from ten to a hundred euros, follow-up prescriptions often between fifteen and twenty euros. An overview of the digital infrastructure behind the cannabis prescription is provided by the report Cannabis prescription online: The modern way to therapy.
An important point for patients choosing the telemedicine route: Most platforms issue private prescriptions. Those seeking health insurance funding should find out in advance whether and how the respective provider supports the statutory health insurance application. Some platforms offer active support here, others do not.
Health insurance application for cannabis on prescription: How to do it right
For those with statutory health insurance seeking cost coverage by the health insurance company, a formal application must be submitted. This step is both the most difficult and the most important – because it determines whether you get the therapy at no cost or must pay as a private patient.
The health insurance company has two weeks from receipt of the application to make a decision. If an expert opinion from the Medical Service (MD) is obtained, this period extends to four weeks. Sounds manageable. But anyone familiar with patient experience reports knows: the process rarely runs smoothly, and the quality of the submitted documents is decisive for the outcome.
About two-thirds of applications are approved – a positive signal. However, this also means that roughly one-third of patients initially receive a rejection. The most common reasons for rejection are incomplete or poorly justified applications, and cases where other treatment options have not been exhausted according to the insurance company’s assessment.
For the application: It’s better to document too much than too little. Test results from the past two years, medical letters, hospital reports, and imaging results – everything that documents the severity of the illness and the failure of previous treatments belongs in the application. A pain diary kept over several weeks can be a strong argument for pain patients that the Medical Service takes particularly seriously. The accompanying medical letter should clearly and comprehensibly explain why standard therapy is no longer appropriate for this patient – not as a general statement, but related to the specific case.
If you receive a rejection, you have one month to file an appeal. The appeal should always be supported by a new medical statement that explicitly explains why standard therapies are not suitable for this patient. This is not merely a repetition of the first application – it is a qualified justification that shows that therapy resistance is medically documented. If the appeal also fails, there is the possibility of free litigation at the competent social court. Well-documented appeals lead to success in a significant proportion of cases.
Private prescription and self-payers: The quick alternative to health insurance application
Not everyone wants or can pursue the health insurance route. For many patients – especially those with diagnoses that the health insurance company still views skeptically, or those who want to start therapy quickly – the private prescription is the more pragmatic entry point.
On a private prescription, medicinal cannabis is billed at the pharmacy as a private service. Prices vary considerably depending on strain, origin, and provider. Dried flowers cost between four and twenty euros per gram at the pharmacy, depending on quality and availability. Extracts and oils can be significantly more expensive. Those planning ongoing medication should realistically calculate monthly costs – a typical patient with moderate needs incurs monthly out-of-pocket costs between 100 and 300 euros.
The advantage of the private prescription lies in speed and independence. No application, no waiting time, no need to justify yourself to a health insurance company. The disadvantage is the financial out-of-pocket expense, which for many patients represents a real burden in the long term. A private prescription does not preclude a later health insurance application. Many patients start with the private prescription to begin therapy quickly and submit the health insurance application in parallel or shortly thereafter. This is a pragmatic strategy that avoids long waits while keeping the path to statutory health insurance funding open.
From prescription to dispensing: Cannabis at the pharmacy
Once the doctor has issued the prescription, the pharmacy is the next step. Not every pharmacy carries medicinal cannabis, but the market is now so broad that supply is guaranteed in most regions of Germany. A pharmacy without cannabis in stock is obligated to order it or suggest an alternative.
Telemedicine platforms often work closely with certain mail-order pharmacies that deliver cannabis throughout Germany. This is the most convenient solution for many patients: the prescription is sent directly from the doctor to the pharmacy, and the medication is delivered to your home. Standard delivery times are one to two business days, and in certain regions express delivery within a few hours is possible. Those who prefer a stationary pharmacy should call ahead to check if the desired strain is in stock – availability of certain strains and batches can fluctuate.
Travelers using medicinal cannabis should know the legal situation in their destination country. Our article Traveling with medicinal cannabis: How patients safely reach their destination in 2026 explains what to consider. As a supplement, the cannabis patient card can be a useful addition in certain situations, even though it is not legally required.
FAQ: Cannabis on prescription in Germany
Which doctor can prescribe cannabis?
Any licensed doctor in Germany may prescribe medicinal cannabis – regardless of their specialty. This applies to general practitioners as well as specialists such as pain therapists, neurologists, or psychiatrists. Only dentists and veterinarians are excluded. In practice, pain therapists and specialists in neurology are particularly active in cannabis therapy.
What are the chances of health insurance coverage?
Currently, approximately two-thirds of initial applications are approved. The chances of success increase significantly if the application is complete, well-documented, and clearly justified medically. If you receive a rejection, it’s worth filing an appeal – especially if there is a new medical statement clearly explaining the necessity of therapy in your specific case.
What does cannabis on prescription cost for self-payers?
Costs vary greatly depending on strain, pharmacy, and form of administration. Dried flowers cost between four and twenty euros per gram. Doctor consultation costs are added: initial consultations at telemedicine platforms cost between ten and a hundred euros, follow-up prescriptions from around fifteen euros. Monthly total costs for self-payers typically range between 100 and 400 euros depending on consumption.
Can you get cannabis on prescription completely online?
Yes. Through telemedicine platforms, patients can obtain a prescription via video consultation without physically visiting a doctor’s office. The prescription is issued digitally and forwarded directly to a pharmacy, which sends the cannabis by mail. This route works smoothly for private prescriptions; with statutory health insurance applications, the process is more complex and requires more personal initiative.
What if the health insurance company rejects the application?
Within one month of receiving the rejection notice, you can file an appeal. The appeal should be supported by a new, detailed medical justification. If the appeal also fails, there is the free option of litigation at the social court. Well-documented appeals with clear medical statements are successful in a considerable number of cases.
Do I need a cannabis patient card?
No, there is no legally required cannabis patient card in Germany. Various organizations offer voluntary cards that can be helpful in everyday life – for example, during police checks or when traveling. Whether it makes sense depends on your individual life situation.
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
